Experimental Evaluation of Dry Powder Inhalers during Inhalation and Exhalation Using a Model of the Human Respiratory System (xPULM™)

Experimental Evaluation of Dry Powder Inhalers during Inhalation and Exhalation Using a Model of the Human Respiratory System (xPULM™)

Dry powder inhalers are used by a large number of patients worldwide to treat respiratory diseases. The objective of this work is to experimentally investigate changes in aerosol particle diameter and particle number concentration of pharmaceutical aerosols generated by four dry powder inhalers unde...

Full description

Bibliographic Details
Main Authors:	Richard Pasteka, Lara Alina Schöllbauer, Joao Pedro Santos da Costa, Radim Kolar, Mathias Forjan
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Pharmaceutics
Subjects:	dry powder inhaler resistance inspiratory flow rate inspiratory pressure aerosol particle deposition mechanical upper airway model optical aerosol spectrometry
Online Access:	https://www.mdpi.com/1999-4923/14/3/500

Similar Items

Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial
by: Pablo Altman, et al.
Published: (2018-06-01)

Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases
by: Kawamatawong T, et al.
Published: (2017-02-01)

Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza
by: Toshiki Murasaka, et al.
Published: (2017-11-01)

Impact of selected construction elements of capsule-based dry powder inhalers on the manner of drug delivery to the lungs
by: Marcin Odziomek, et al.
Published: (2016-12-01)

Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD
by: Alfredo Chetta, et al.
Published: (2021-02-01)

Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD
by: Jõgi R, et al.
Published: (2021-04-01)

The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions
by: Árpád Farkas, et al.
Published: (2023-12-01)

Experimental Study on the Transport and Alteration Behavior of Aerosols From Low Density Powders for Acute Inhalation Toxicology Studies
by: Benno Wessely, et al.
Published: (2022-06-01)

In vitro Evaluation of Dry Powder Inhaler Devices of Corticosteroid Preparations
by: Gen Tamura, et al.
Published: (2012-01-01)

Respimat as the new standard for inhalation therapy devices
by: V. V. Arkhipov
Published: (2021-10-01)

Inhalation of aerosols by children: an ongoing controversy
by: Swiss Medical Weekly
Published: (2004-04-01)

A Comparison of Aerosol Performance Using Standardized Entrainment Tubes vs. Dry Powder Inhaler Devices
by: Zhen Xu, et al.
Published: (2013-12-01)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
by: Helena Gauani, et al.
Published: (2023-03-01)

Suboptimal Inspiratory Flow Rates With Passive Dry Powder Inhalers: Big Issue or Overstated Problem?
by: Jeffry Weers
Published: (2022-03-01)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
by: Zitong Shao, et al.
Published: (2021-11-01)

Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder
by: Helena Gauani, et al.
Published: (2022-04-01)

TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow
by: Mahler DA, et al.
Published: (2021-08-01)

Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilization
by: Rachel Yoon Kyung Chang, et al.
Published: (2020-05-01)

Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model
by: Philip J. Kuehl, et al.
Published: (2018-01-01)

A complementary combination of delivery device and drug formulation for inhalation therapy in preschool children
by: KG Schüepp, et al.
Published: (2004-04-01)

Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion
by: Baloira A, et al.
Published: (2021-04-01)

Delivery of theophylline as dry powder for inhalation
by: Bing Zhu, et al.
Published: (2015-12-01)

Development of a murine nose-only inhalation model of influenza: Comparison of disease caused by instilled and inhaled A/PR/8/34
by: Larry E. Bowen, et al.
Published: (2012-05-01)

Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion [Corrigendum]
by: Baloira A, et al.
Published: (2021-08-01)

Patient–Ventilator Interaction Testing Using the Electromechanical Lung Simulator xPULM™ during V/A-C and PSV Ventilation Mode
by: Richard Pasteka, et al.
Published: (2021-04-01)

Engineering Inhalable Therapeutic Particles: Conventional and Emerging Approaches
by: Aditi Negi, et al.
Published: (2023-11-01)

Position of different nebulizer types for aerosol delivery in an adult model of mechanical ventilation
by: Haijia Hou, et al.
Published: (2022-10-01)

A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD
by: De Backer W, et al.
Published: (2018-08-01)

Pharmaceutical inhalation aerosol technology /
by: Hickey, Anthony J., 1955-
Published: (2004)

Editorial: Strategies to overcome the barriers to effective inhaled treatments
by: Philip Chi Lip Kwok, et al.
Published: (2023-07-01)

Inhalational Monkeypox Virus Infection in Cynomolgus Macaques
by: Roy eBarnewall, et al.
Published: (2012-09-01)

Evaluation of Peak Inspiratory Flow Rate in Hospitalized Palliative Care Patients with COPD
by: Joshua Borris, et al.
Published: (2023-07-01)

The effect of lung emptying before the inhalation of aerosol drugs on drug deposition in the respiratory system
by: Árpád Farkas, et al.
Published: (2023-12-01)

Carrier-Free Inhalable Dry Microparticles of Celecoxib: Use of the Electrospraying Technique
by: Azin Jahangiri, et al.
Published: (2023-06-01)

Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization
by: Basanth Babu Eedara, et al.
Published: (2023-09-01)

Inhalation d'aérosols liquides ou solides chez les Primates Non Humains
by: Jérôme Montharu, et al.
Published: (2015-03-01)

Performance Testing for Dry Powder Inhaler Products: Towards Clinical Relevance
by: Sara E. Maloney, et al.
Published: (2022-09-01)

Rola przepływu wdechowego w optymalnej technice inhalacji z DPI i metody jego pomiaru = Role inspiratory flow at optimal inhalation with a DPI technology and its methods of measurement
by: Iwona Czerwińska Pawluk, et al.
Published: (2015-01-01)

Rola przepływu wdechowego w optymalnej technice inhalacji z DPI i metody jego pomiaru = Role inspiratory flow at optimal inhalation with a DPI technology and its methods of measurement
by: Iwona Czerwińska Pawluk, et al.
Published: (2015-01-01)

Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease
by: Natalia V. Trushenko, et al.
Published: (2023-04-01)